Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al: Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008, 3 (11): e3694-10.1371/journal.pone.0003694.
Article
PubMed
PubMed Central
Google Scholar
Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H: Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol. 2011, 5 (3): 281-291. 10.1016/j.molonc.2011.02.002.
Article
CAS
PubMed
Google Scholar
Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H: Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Canc Res. 2010, 12 (6): R90-10.1186/bcr2766.
Article
CAS
Google Scholar
Chadeau-Hyam M, Ebbels TM, Brown IJ, Chan Q, Stamler J, Huang CC, Daviglus ML, Ueshima H, Zhao L, Holmes E, et al: Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. J Proteome Res. 2010, 9 (9): 4620-4627. 10.1021/pr1003449.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee K, Hwang D, Yokoyama T, Stephanopoulos G, Stephanopoulos GN, Yarmush ML: Identification of optimal classification functions for biological sample and state discrimination from metabolic profiling data. Bioinformatics. 2004, 20 (6): 959-969. 10.1093/bioinformatics/bth015.
Article
CAS
PubMed
Google Scholar
Kim Y, Koo I, Jung BH, Chung BC, Lee D: Multivariate classification of urine metabolome profiles for breast cancer diagnosis. BMC Bioinforma. 2010, 11 (2): S4-
Article
Google Scholar
Nolen B, Velikokhatnaya L, Marrangoni A, De Geest K, Lomakin A, Bast RC, Lokshin A: Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol. 2010, 117 (3): 440-445. 10.1016/j.ygyno.2010.02.005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, Chiong E, Chan EC: Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res. 2010, 9 (6): 2988-2995. 10.1021/pr901173v.
Article
CAS
PubMed
Google Scholar
Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, et al: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009, 8 (10): 4844-4850. 10.1021/pr9004162.
Article
CAS
PubMed
Google Scholar
Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, et al: Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res. 2008, 7 (4): 1693-1703. 10.1021/pr700706s.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Humpfer E, Spraul M, Carreira IM, Melo JB, Bernardo J, Gomes A, et al: Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res. 2010, 9 (1): 319-332. 10.1021/pr9006574.
Article
CAS
PubMed
Google Scholar
Urayama S, Zou W, Brooks K, Tolstikov V: Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom. 2010, 24 (5): 613-620. 10.1002/rcm.4420.
Article
CAS
PubMed
Google Scholar
Felig P, Marliss E, Ohman JL, Cahill CF: Plasma amino acid levels in diabetic ketoacidosis. Diabetes. 1970, 19 (10): 727-728.
Article
CAS
PubMed
Google Scholar
Felig P, Wahren J, Raf L: Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci USA. 1973, 70 (6): 1775-1779. 10.1073/pnas.70.6.1775.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI, Yoshimura N, Westman T: The role of plasma amino acids in hepatic encephalopathy. Surgery. 1975, 78 (3): 276-290.
CAS
PubMed
Google Scholar
Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB: The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976, 80 (1): 77-91.
CAS
PubMed
Google Scholar
Kimura T, Noguchi Y, Shikata N, Takahashi M: Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care. 2009, 12 (1): 49-53. 10.1097/MCO.0b013e3283169242.
Article
CAS
PubMed
Google Scholar
Noguchi Y, Zhang QW, Sugimoto T, Furuhata Y, Sakai R, Mori M, Takahashi M, Kimura T: Network analysis of plasma and tissue amino acids and the generation of an amino index for potential diagnostic use. Am J Clin Nutr. 2006, 83 (2): 513S-519S.
CAS
PubMed
Google Scholar
Cascino A, Cangiano C, Ceci F, Franchi F, Mineo T, Mulieri M, Muscaritoli M, Rossi Fanelli F: Increased plasma free tryptophan levels in human cancer: a tumor related effect?. Anticancer Res. 1991, 11 (3): 1313-1316.
CAS
PubMed
Google Scholar
Cascino A, Muscaritoli M, Cangiano C, Conversano L, Laviano A, Ariemma S, Meguid MM, Rossi Fanelli F: Plasma amino acid imbalance in patients with lung and breast cancer. Anticancer Res. 1995, 15 (2): 507-510.
CAS
PubMed
Google Scholar
Kubota A, Meguid MM, Hitch DC: Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors. Cancer. 1992, 69 (9): 2343-2348. 10.1002/1097-0142(19920501)69:9<2343::AID-CNCR2820690924>3.0.CO;2-S.
Article
CAS
PubMed
Google Scholar
Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ: Plasma free amino acid profile in cancer patients. Semin Canc Biol. 2005, 15 (4): 267-276. 10.1016/j.semcancer.2005.04.003.
Article
CAS
Google Scholar
Laviano A, Cascino A, Muscaritoli M, Fanfarillo F, Rossi Fanelli F: Tumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease. Adv Exp Med Biol. 2003, 527: 363-366. 10.1007/978-1-4615-0135-0_41.
Article
CAS
PubMed
Google Scholar
Naini AB, Dickerson JW, Brown MM: Preoperative and postoperative levels of plasma protein and amino acid in esophageal and lung cancer patients. Cancer. 1988, 62 (2): 355-360. 10.1002/1097-0142(19880715)62:2<355::AID-CNCR2820620221>3.0.CO;2-E.
Article
CAS
PubMed
Google Scholar
Norton JA, Gorschboth CM, Wesley RA, Burt ME, Brennan MF: Fasting plasma amino acid levels in cancer patients. Cancer. 1985, 56 (5): 1181-1186. 10.1002/1097-0142(19850901)56:5<1181::AID-CNCR2820560535>3.0.CO;2-8.
Article
CAS
PubMed
Google Scholar
Proenza AM, Oliver J, Palou A, Roca P: Breast and lung cancer are associated with a decrease in blood cell amino acid content. J Nutr Biochem. 2003, 14 (3): 133-138. 10.1016/S0955-2863(02)00225-5.
Article
CAS
PubMed
Google Scholar
Vissers YL, Dejong CH, Luiking YC, Fearon KC, von Meyenfeldt MF, Deutz NE: Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?. Am J Clin Nutr. 2005, 81 (5): 1142-1146.
CAS
PubMed
Google Scholar
Fontana S, Alessandro R, Barranca M, Giordano M, Corrado C, Zanella-Cleon I, Becchi M, Kohn EC, De Leo G: Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines. J Proteome Res. 2007, 6 (11): 4330-4342. 10.1021/pr0704128.
Article
CAS
PubMed
Google Scholar
Shimbo K, Kubo S, Harada Y, Oonuki T, Yokokura T, Yoshida H, Amao M, Nakamura M, Kageyama N, Yamazaki J, et al: Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry. Biomed Chromatogr. 2009, 24 (7): 683-691. 10.1002/bmc.1346.
Article
Google Scholar
Shimbo K, Oonuki T, Yahashi A, Hirayama K, Miyano H: Precolumn derivatization reagents for high-speed analysis of amines and amino acids in biological fluid using liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009, 23 (10): 1483-1492. 10.1002/rcm.4026.
Article
CAS
PubMed
Google Scholar
Shimbo K, Yahashi A, Hirayama K, Nakazawa M, Miyano H: Multifunctional and highly sensitive precolumn reagents for amino acids in liquid chromatography/tandem mass spectrometry. Anal Chem. 2009, 81 (13): 5172-5179. 10.1021/ac900470w.
Article
CAS
PubMed
Google Scholar
Maeda J, Higashiyama M, Imaizumi A, Nakayama T, Yamamoto H, Daimon T, Yamakado M, Imamura F, Kodama K: Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Canc. 2010, 10 (1): 690-10.1186/1471-2407-10-690.
Article
CAS
Google Scholar
Okamoto N, Miyagi Y, Chiba A, Akaike M, Shiozawa M, Imaizumi A, Yamamoto H, Ando T, Yamakado M, Tochikubo O: Diagnostic modeling with differences in plasma amino acid profiles between non-cachectic colorectal/breast cancer patients and healthy individuals. Int J Med Med Sci. 2009, 1 (1): 1-8.
CAS
Google Scholar
Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T, Saruki N, Bando E, Kimura H, Imamura F, et al: Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One. 2011, 6 (9): e24143-10.1371/journal.pone.0024143.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okamoto N: Cancer screening using “AminoIndex Technology”. Ningen Dock. 2011, 26 (3): 454-466.
Google Scholar
Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Shimokata K, Inoue H, et al: A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008, 3 (1): 46-52. 10.1097/JTO.0b013e31815e8577.
Article
PubMed
Google Scholar
Sumitani M, Takifuji N, Nanjyo S, Imahashi Y, Kiyota H, Takeda K, Yamamoto R, Tada H: Clinical relevance of sputum cytology and chest X-ray in patients with suspected lung tumors. Intern Med. 2008, 47 (13): 1199-1205. 10.2169/internalmedicine.47.0777.
Article
PubMed
Google Scholar
Sobin L, Wittekind C: TNM Classification of Malignant Tumours, Sixth Edition. 2002, New York: Wiley-Liss
Google Scholar
Ando S, Kimura H, Iwai N, Kakizawa K, Shima M, Ando M: The significance of tumour markers as an indication for mediastinoscopy in non-small cell lung cancer. Respirology. 2003, 8 (2): 163-167. 10.1046/j.1440-1843.2003.00443.x.
Article
PubMed
Google Scholar
Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982, 143 (1): 29-36.
Article
CAS
PubMed
Google Scholar
Molina R, Auge JM, Filella X, Vinolas N, Alicarte J, Domingo JM, Ballesta AM: Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21–1 and NSE in patients with lung cancer. Anticancer Res. 2005, 25 (3A): 1773-1778.
CAS
PubMed
Google Scholar